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During the past two decades, transcranial sonog-
raphy (TCS) has developed to an increasingly used 
brain imaging method that visualizes characteristic 
patterns of brain structures alterations in distinct 
movement disorders. Findings of abnormal hyper-
echogenic appearance of substantia nigra (SN) on 
TCS in Parkinson’s disease (PD), which is stable dur-
ing the course of the disease and probably present al-
ready in preclinical disease stages have promoted the 
idea that this TCS fi nding in healthy subjects might 
be a risk marker of PD. 
Hyperechogenicity of the SN is a typical fi nding 
in about 90% of patients with PD, but not in patients 
with essential tremor (ET). In ET patients, the prev-
alence of hyperechogenicity is in the range of healthy 
control subjects or slightly above, which may indicate 
an increased risk for PD in the subgroup of ET pa-
tients with SN hyperechogenicity.
TCS fi ndings in restless legs syndrome (RLS) in-
clude hypoechogenicity of the substantia nigra and 
raphe as well as hyperechogenicity of the red nucleus.
Transcranial sonography (TCS) can detect trace 
metal accumulation in deep brain structures with 
higher sensitivity than conventional MRI. Increased 
iron content in the substantia nigra in Parkinson’s 
disease, increased copper content in the lenticular 
nucleus (LN) in Wilson’s disease and idiopathic dys-
tonia, and increased manganese content in the LN in 
manganese-induced Parkinsonism. 
No characteristic abnormalities were found in the 
basal ganglia of primary dystonia patients. It remains to 
be explored whether this is due to a true absence of sig-
nal alterations in the basal ganglia of dystonia patients 
or to limitations of the current technology used.
Th e TCS fi nding of substantia nigra hyperecho-
genicity in Huntington’s disease (HD) was related 
to higher clinical disease severity. A poorer cogni-
tive performance correlated with larger width of third 
ventricle. Moreover, widths of frontal horns of lateral 
ventricles measured with TCS corresponded closely 
to diameters estimated by CT imaging. Depressive 
symptoms were found to be associated with abnor-
mal echogenicity of mesencephalic raphe structures. 
Furthermore, a larger number of CAG repeats in the 
huntingtin gene correlated with presence of SN hy-
perechogenicity.
TCS also reveals signal alterations of basal gan-
glia in several forms of hereditary and nonhereditary 
ataxia. hyperechogenicity of substantia nigra (SN) as 
a frequent fi nding in spinocerebellar ataxia type 2, 
type 3, and type 17, indicating a vulnerability of the 
nigrostriatal system in SCA patients. A new “cerebel-
lar examination plane” was proposed, allowing bet-
ter visualization of fourth ventricle enlargement and 
nucleus dentatus hyperechogenicity as a characteristic 
fi nding in SCA3 patients. 
In sporadic Creutzfeldt-Jakob disease, a blurry 
inhomogeneous hyperechogenic signal pattern of 
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lentiform nucleus was identifi ed in all of the patients 
in a small case series. Furthermore, distinct bilateral 
hyperechogenicity of pallidostriatal regions have been 
described as a novel diagnostic feature in the sono-
graphic diff erentiation of extrapyramidal and atactic 
movement disorders.
TCS has shown correlation of raphe hypoechoge-
nicity and primary depressive disorders such as major 
depression and depression in Parkinson’s disease.
TCS is a commonly available, noninvasive, and 
inexpensive diagnostic tool, which provides reliable 
information about the morphology of the brain, even 
in agitated patients who do not tolerate other imaging 
techniques.
